Synbody Biotechnology, Inc. — Form D
Synbody Biotechnology, Inc. of FARMINGTON, CT, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-20. The offering totals $250K, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-11-20
- Form: D
- Accession: 0001544401-12-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $250K
- Amount sold: $250K
- Investors: 1
- Date of first sale: 2012-11-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-187273
Issuer
- Name: Synbody Biotechnology, Inc.
- CIK: 0001544401
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 400 FARMINGTON AVE., FARMINGTON, CT, 06032
- Phone: 484-883-9725
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Daniel W Wagner | Director | Rocky Hill, CT |
| Kevin D Burroughs | Executive Officer | Farmington, CT |
| Paul L Hallenbeck | Director | Farmington, CT |
| Paul L Hallenbeck | Executive Officer | Farmington, CT |
Other filings by this issuer (1)
More